Hexokinase 2 in cancer: a prima donna playing multiple characters

F Ciscato, L Ferrone, I Masgras, C Laquatra… - International journal of …, 2021 - mdpi.com
Hexokinases are a family of ubiquitous exose-phosphorylating enzymes that prime glucose
for intracellular utilization. Hexokinase 2 (HK2) is the most active isozyme of the family …

Thyroid hormones in diabetes, cancer, and aging

BR Gauthier, A Sola‐García, MÁ Cáliz‐Molina… - Aging cell, 2020 - Wiley Online Library
Thyroid function is central in the control of physiological and pathophysiological processes.
Studies in animal models and human research have determined that thyroid hormones …

Nonalcoholic fatty liver disease and endocrine axes—a scoping review

M Von-Hafe, M Borges-Canha, C Vale, AR Leite… - Metabolites, 2022 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease.
NAFLD often occurs associated with endocrinopathies. Evidence suggests that endocrine …

[HTML][HTML] Reprogramming of central carbon metabolism in hepatocellular carcinoma

H Xia, Z Huang, Y Xu, JWP Yam, Y Cui - Biomedicine & Pharmacotherapy, 2022 - Elsevier
In multicellular organisms, nutrient uptake and its metabolism are subject to stringent
regulation to maintain cellular integrity and prevent aberrant cell proliferation. However, the …

[HTML][HTML] Hepatocyte smoothened activity controls susceptibility to insulin resistance and nonalcoholic fatty liver disease

T Chen, G Dalton, SH Oh, R Maeso-Diaz, K Du… - Cellular and Molecular …, 2023 - Elsevier
Background & Aims Nonalcoholic steatohepatitis (NASH), a leading cause of cirrhosis,
strongly associates with the metabolic syndrome, an insulin-resistant proinflammatory state …

Differentiation therapy: Unlocking phenotypic plasticity of hepatocellular carcinoma

S Zheng, H Bian, J Li, Y Shen, Y Yang, W Hu - Critical Reviews in …, 2022 - Elsevier
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. The current
treatment of HCC mainly includes surgery, chemotherapy, and liver transplantation. HCC …

An extended transcription factor regulatory network controls hepatocyte identity

J Dubois‐Chevalier, C Gheeraert, A Berthier… - EMBO …, 2023 - embopress.org
Cell identity is specified by a core transcriptional regulatory circuitry (CoRC), typically limited
to a small set of interconnected cell‐specific transcription factors (TFs). By mining global …

Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes

MA Kowalik, K Taguchi, M Serra, A Caddeo… - Hepatology, 2024 - journals.lww.com
Conclusions: Many metabolic changes in cancer cells are shared by proliferating normal
hepatocytes in response to a hostile environment. Nrf2 activation is essential for bridging …

[HTML][HTML] Potential use of TG68-A novel thyromimetic-for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis

A Caddeo, M Serra, F Sedda, A Bacci, C Manera… - Frontiers in …, 2023 - frontiersin.org
Introduction Several lines of evidence suggest that the thyroid hormone signaling pathway is
altered in patients with NAFLD and that pharmacological strategies to target the thyroid …

Epigenome-Wide Association Study of Thyroid Function Traits Identifies Novel Associations of fT3 With KLF9 and DOT1L

N Lafontaine, PJ Campbell… - The Journal of …, 2021 - academic.oup.com
Context Circulating concentrations of free triiodothyronine (fT3), free thyroxine (fT4), and
thyrotropin (TSH) are partly heritable traits. Recent studies have advanced knowledge of …